1. Home
  2. NXLIW

NXLIW

Nexalin Technology Inc. Warrant

Logo Nexalin Technology Inc. Warrant

Health Care

Medical Specialities

Nasdaq

as 03-13-2024 2:06pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
-
-
.
-
-
%

Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Founded: N/A Country:
United States
United States
Employees: 6 City: N/A
Market Cap: N/A IPO Year: 2022
Target Price: N/A AVG Volume (30 days): N/A
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: N/A Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: